References

Abdolrasouli A, Barton RC, Borman AM Spread of antifungal-resistant Trichophyton indotineae, United Kingdom, 2017–2024. Emerg Infect Dis. 2025; 31:(1)192-194 https://doi.org/10.3201/eid3101.240923

Agarwal R, Muthu V, Sehgal IS Relationship between Aspergillus and asthma. Allergol Int. 2023; 72:(4)507-520 https://doi.org/10.1016/j.alit.2023.08.004

Bui TS, Katz KA Resistant Trichophyton indotineae dermatophytosis-an emerging pandemic, now in the US. JAMA Dermatol. 2024; 160:(7)699-700 https://doi.org/10.1001/jamadermatol.2024.1125

Casadevall A, Desmon S What if fungi win?.Baltimore: Johns Hopkins University Press; 2024

Casalini G, Giacomelli A, Antinori S The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation. Lancet Microbe. 2024; 5:(7)717-724 https://doi.org/10.1016/s2666-5247(24)00042-9

Chanyachailert P, Leeyaphan C, Bunyaratavej S Cutaneous fungal infections caused by dermatophytes and non-dermatophytes: an updated comprehensive review of epidemiology, clinical presentations, and diagnostic testing. J Fungi. 2023; 9:(6) https://doi.org/10.3390/jof9060669

Dellière S, Jabet A, Abdolrasouli A Current and emerging issues in dermatophyte infections. PLoS Pathog. 2024; 20:(6) https://doi.org/10.1371/journal.ppat.1012258

Gkini MA, Nakamura M, Alexis AF Psoriasis in people with skin of color: an evidence-based update. Int J Dermatol. 2025; 64:(4)667-677 https://doi.org/10.1111/ijd.17651

Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J Psoriasis. Lancet. 2021; 397:(10281)1301-1315 https://doi.org/10.1016/s0140-6736(20)32549-6

Gupta AK, Stec N, Summerbell RC Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020; 34:(9)1972-1990 https://doi.org/10.1111/jdv.16394

Gupta AK, Venkataraman M, Talukder M Onychomycosis in older adults: prevalence, diagnosis, and management. Drugs Aging. 2022; 39:(3)191-198 https://doi.org/10.1007/s40266-021-00917-8

Gupta AK, Wang T, Polla Ravi S, Mann A, Bamimore MA Global prevalence of onychomycosis in general and special populations: an updated perspective. Mycoses. 2024; 67:(4) https://doi.org/10.1111/myc.13725

Hill RC, Caplan AS, Elewski B Expert panel review of skin and hair dermatophytoses in an era of antifungal resistance. Am J Clin Dermatol. 2024; 25:(3)359-389 https://doi.org/10.1007/s40257-024-00848-1

Jartarkar SR, Patil A, Goldust Y Pathogenesis, immunology and management of dermatophytosis. J Fungi. 2022; 8:(1) https://doi.org/10.3390/jof8010039

Kruithoff C, Gamal A, McCormick TS, Ghannoum MA Dermatophyte infections worldwide: increase in incidence and associated antifungal resistance. Life. 2024; 14:(1) https://doi.org/10.3390/life14010001

Kyriakou A, Zagalioti SC, Trakatelli MG Fungal infections and nail psoriasis: an update. J Fungi. 2022; 8:(2) https://doi.org/10.3390/jof8020154

Lee DK, Lipner SR Optimal diagnosis and management of common nail disorders. Ann Med. 2022; 54:(1)694-712 https://doi.org/10.1080/07853890.2022.2044511

Liu M, Kang Y, Zhang R The prevalence of onchomycosis in psoriasis patients: a systematic review and meta-analysis. Mycoses. 2025; 68:(2) https://doi.org/10.1111/myc.70035

NHS. Ringworm. 2023. https://www.nhs.uk/conditions/ringworm/ (accessed 29 April 2024)

Rippon JW The changing epidemiology and emerging patterns of dermatophyte species. In: McGinnis MR (ed). New York (NY): Springer; 1985

Rokas A Evolution of the human pathogenic lifestyle in fungi. Nature Microbiol. 2022; 7:(5)607-619 https://doi.org/10.1038/s41564-022-01112-0

Sacheli R, Hayette M-P Antifungal resistance in dermatophytes: genetic considerations, clinical presentations and alternative therapies. J Fungi. 2021; 7:(11) https://doi.org/10.3390/jof7110983

Suphatsathienkul P, Jirawattanadon P, Matthapan L Tinea manuum: a 5 year retrospective study of demographic data, clinical characteristics, and treatment outcomes. Sci Rep. 2025; 15:(1) https://doi.org/10.1038/s41598-025-87011-w

White TC, Findley K, Dawson TL Fungi on the skin: dermatophytes and Malassezia. Cold Spring Harb Perspect Med. 2014; 4:(8) https://doi.org/10.1101/cshperspect.a019802

Zaraa I, Dehavay F, Richert B Onychomycosis. Hand Surg Rehabil. 2024; 43S https://doi.org/10.1016/j.hansur.2024.101638

Fungal infections: community nursing approaches to skin and nail care

02 June 2025
Volume 30 · Issue 6

Abstract

Dermatophytes (ringworms) are possibly the most prevalent causes of human infection globally. At least 40 dermatophyte species infect humans. For example, onychomycosis, which is responsible for about half of abnormal nails, may: produce ridging, ingrown nails, bleeding and nail loss; make walking painful; and facilitate secondary bacterial infections. Several diseases increase the risk of onychomycosis caused by dermatophytes, including knee osteoarthritis and poorly controlled diabetes. This article focuses on nursing approaches to managing skin and nail dermatophyte infections. Topical antifungals are generally the first-line treatment for tinea corporis, cruris and pedis. Oral antifungals may be appropriate for tinea capitis, onychomycosis, extensive skin infections or if topical treatment does not resolve the infection. Antifungal resistance is becoming more common. However, community nurses should address poor adherence and other possible causes of treatment failure before assuming antifungal resistance. Community nurses should also ensure that patients are diagnosed and treated rapidly, and suggest lifestyle changes that reduce the risk of antifungal failure, infection and relapse.

Over the years, people have become used to the idea that bacteria colonise our skin, guts and genitalia, and recognise that changes to the microbiome cause or contribute to myriad conditions, such as atopic dermatitis, antibiotic-associated diarrhoea and bacterial vaginosis. However, fungi are often forgotten. Feet, for instance, potentially harbour almost 200 different fungal species (Casadevall and Desmon, 2024).

Worldwide, dermatophytes (ringworm) may be the most common causes of human infections, bacteria and viruses notwithstanding (White et al, 2014). It is important to adopt effective nursing approaches to manage dermatophytes, which infect skin, hair and nails, and can cause deep-tissue infections in immunosuppressed people (Dellière et al, 2024).

At least 40 dermatophyte species can infect humans by ‘sticking’ to the stratum corneum, the skin's outer layer (White et al, 2014; Hill et al, 2024). Long hyphae grow into the underlying skin and break down keratin, which dermatophytes use to fuel growth (Hill et al, 2024). Between 30% and 70% of people harbour dermatophytes without experiencing any symptoms (White et al, 2014). However, some individuals experience an inflammatory response intended to eliminate the dermatophyte (Jartarkar et al, 2022; Rokas, 2022; Hill et al, 2024).

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month